


Volume 20 No 17 (2022)
Download PDF
In Silico Evaluation of the compounds of Siddha herbal formulation Panchakarpa Mathirai against Gaba (A) Receptor in the management of Anxiety and Seizure
Sabari Girija N, Sinekha M A, Shanmugapriya P, Ramamurthy M, Christian G J, Meenakumari R
Abstract
Central nervous system (CNS) depressants are drugs that calms down the CNS. These drugs are used for the treatment of anxiety and seizure. GABA is the principal inhibitory neurotransmitter of the central nervous system. CNS depressants brings about their effects by acting on the GABAA receptors of the Central nervous system. In Siddha system of medicine, mental illness is mentioned as “Brammai”. Pancha karpa mathirai is the Siddha herbal formulation widely used for mana noigal (psychiatric illness). Thus, the present study was undertaken to evaluate the Pancha karpa mathirai against the GABAA receptor through in-silico approaches. Docking calculations were carried out for retrieved phytocomponents against target GABA- A receptor by auto dock program. Total of 10 bioactive lead compounds were retrieved from the herbs, from the reported data of the herb, the phytochemical Chebuloside possess 3 interactions out of 4 target core active amino acid residues present on the GABAA receptor which signifies 75% of the binding efficacy. Thereby it was concluded that these compounds may exert promising anxiolytic and anti-convulsant activity.
Keywords
Anxiolytic, anti-anxiety, panchakarpa mathirai, docking study, Siddha.
Copyright
Copyright © Neuroquantology
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.